BCL2 and prostate cancer: The active fraction exerted its anti-proliferative properties by increasing the expression of Bax and Smac/DIABLO (diablo IAP-binding mitochondrial protein) and downregulating the expression of Bcl-2 in PC3 prostate cancer cells, which leads to apoptosis.